Eton Pharmaceuticals (ETON) Cash from Operations (2018 - 2025)

Eton Pharmaceuticals has disclosed Cash from Operations across 8 years of filings, most recently posting 11551000.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 11551000.0, down 1409.93% year-over-year; the trailing twelve-month figure through Dec 2025 was 10524000.0 (up 986.07% YoY), and the FY2025 annual result was 10524000.0, up 986.07% from the prior year.
• Cash from Operations came in at 11551000.0 for Q4 2025 at Eton Pharmaceuticals, down from 12026000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 12026000.0 in Q3 2025 to a low of 11551000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 1048000.0 (2022), against an average of 920400.0.
• Across the five-year window, Cash from Operations soared 766.94% in 2022 and sank 1409.93% in 2025, its largest moves.
• Eton Pharmaceuticals' Cash from Operations stood at 5117000.0 in 2021, then jumped by 155.5% to 2840000.0 in 2022, then tumbled by 86.37% to 387000.0 in 2023, then tumbled by 297.67% to 765000.0 in 2024, then tumbled by 1409.93% to 11551000.0 in 2025.
• The last three Cash from Operations figures came in at 11551000.0 (Q4 2025), 12026000.0 (Q3 2025), and 7959000.0 (Q2 2025), per Business Quant data.